wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49873786-6CA28A37-F947-4E86-A3BD-6F62D08289EC
Q49873786-6CA28A37-F947-4E86-A3BD-6F62D08289EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49873786-6CA28A37-F947-4E86-A3BD-6F62D08289EC
Cost-effectiveness of nivolumab in patients with advanced renal cell carcinoma treated in the United States.
P2860
Q49873786-6CA28A37-F947-4E86-A3BD-6F62D08289EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49873786-6CA28A37-F947-4E86-A3BD-6F62D08289EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d140ac3ce4a7820420d8a377775ea317dd5b49c8
P2860
Economic evaluation of nivolumab as a second-line treatment for advanced renal cell carcinoma from US and Chinese perspectives.